(Q41921456)

14 October 2017

Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children (English)

1 reference

Plasmodium falciparum malaria

14 October 2017

0 references

Plasmodium falciparum

0 references

0 references

1 reference

1 reference

1

Deloron P

1 reference

14 October 2017

Mayombo J

2

1 reference

14 October 2017

Le Cardinal A

3

1 reference

14 October 2017

Mezui-Me-Ndong J

4

1 reference

14 October 2017

Bruzi-Baert C

5

1 reference

14 October 2017

Lekoulou F

6

1 reference

14 October 2017

Elissa N

7

1 reference

14 October 2017

1 March 2000

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

14 October 2017

1 reference

14 October 2017

94

1 reference

14 October 2017

2

1 reference

14 October 2017

188-190

1 reference

A systematic approach to the development of a rational malaria treatment policy in Zambia

14 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Relationships between malaria prevalence and malaria-related morbidity in school children from two villages in central Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990272-4

7 January 2021

10.1016/S0035-9203(00)90272-4

Identifiers

DOI

1 reference

14 October 2017

1 reference